This review highlights the most recent scientific evidence on FPLD3, including the role of PPARγ in adipose tissue metabolism and the phenotypic consequences of loss-of-function variants in the PPARG ...

Others with clinical depression may experience an increase ... because they may not be able to notice any significant weight loss or weight gain if they don’t see you in person.

A total of 14 million Medicare beneficiaries receive the Low-Income Subsidy (LIS), which reduces cost sharing in Medicare Part D. Losing the LIS may impede medication access and affect mortality.

Therefore, this study aimed to examine the links between appetite loss and clinical symptoms as well as inflammatory cytokines levels in this population. Methods: Between January and December 2021, ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference.

HealthDay News — For older adults with untreated hearing loss, a hearing intervention reduces social isolation, according to a study published in JAMA Internal Medicine. Nicholas S. Reed ...

Eli Lilly already posted preliminary data showing its obesity drug, Zepbound topped Novo Nordisk’s Wegovy on measures of weight loss in a head-to-head clinical trial. More detailed results ...

and clinical dietary recommendations. 1-3 This article critically examines the potential of cottage cheese to support weight loss and analyzes its nutritional composition, satiety effects ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

New research being presented at this year’s European Congress on Obesity (ECO 2025) has found that patients of an online obesity clinic achieved similar weight loss to that reported in clinical ...